Navamedic ASA (“Navamedic”, OSE: NAVA) announces it has won the tender for certain antibiotics to the Norwegian hospital market
As announced on 4 August 2020, Navamedic completed the acquisition of the marketing authorisations in the Nordics for a portfolio of antibiotics for intravenous injection or infusion in a hospital setting with an annual turnover of approximately NOK 25 million. Antibiotics for hospital use are in the Nordics mostly purchased through national or regional tenders, wherein suppliers of the products compete to win the entire supply for periods of two years. The decision is based upon a set of pre-defined criteria including price, product characteristics, user friendliness, security of supply,